361 related articles for article (PubMed ID: 31288724)
1. Targeting the 5-HT2C Receptor in Biological Context and the Current State of 5-HT2C Receptor Ligand Development.
Wold EA; Wild CT; Cunningham KA; Zhou J
Curr Top Med Chem; 2019; 19(16):1381-1398. PubMed ID: 31288724
[TBL] [Abstract][Full Text] [Related]
2. A short history of the 5-HT
Palacios JM; Pazos A; Hoyer D
Psychopharmacology (Berl); 2017 May; 234(9-10):1395-1418. PubMed ID: 28265714
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of Action of Cassiae Semen for Weight Management: A Computational Molecular Docking Study of Serotonin Receptor 5-HT2C.
Yuen H; Hung A; Yang AWH; Lenon GB
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32079105
[TBL] [Abstract][Full Text] [Related]
4. Discovery of 4-Phenylpiperidine-2-Carboxamide Analogues as Serotonin 5-HT
Wold EA; Garcia EJ; Wild CT; Miszkiel JM; Soto CA; Chen J; Pazdrak K; Fox RG; Anastasio NC; Cunningham KA; Zhou J
J Med Chem; 2020 Jul; 63(14):7529-7544. PubMed ID: 32567857
[TBL] [Abstract][Full Text] [Related]
5. Insights into the influence of 5-HT2c aminoacidic variants with the inhibitory action of serotonin inverse agonists and antagonists.
Galeazzi R; Massaccesi L; Piva F; Principato G; Laudadio E
J Mol Model; 2014 Mar; 20(3):2120. PubMed ID: 24562856
[TBL] [Abstract][Full Text] [Related]
6. 5-HT2C receptor modulators: a patent survey.
Lee J; Jung ME; Lee J
Expert Opin Ther Pat; 2010 Nov; 20(11):1429-55. PubMed ID: 20849206
[TBL] [Abstract][Full Text] [Related]
7. A Positive Allosteric Modulator of the Serotonin 5-HT
García-Cárceles J; Decara JM; Vázquez-Villa H; Rodríguez R; Codesido E; Cruces J; Brea J; Loza MI; Alén F; Botta J; McCormick PJ; Ballesteros JA; Benhamú B; Rodríguez de Fonseca F; López-Rodríguez ML
J Med Chem; 2017 Dec; 60(23):9575-9584. PubMed ID: 29116785
[TBL] [Abstract][Full Text] [Related]
8. 5-HT
Peng Y; McCorvy JD; Harpsøe K; Lansu K; Yuan S; Popov P; Qu L; Pu M; Che T; Nikolajsen LF; Huang XP; Wu Y; Shen L; Bjørn-Yoshimoto WE; Ding K; Wacker D; Han GW; Cheng J; Katritch V; Jensen AA; Hanson MA; Zhao S; Gloriam DE; Roth BL; Stevens RC; Liu ZJ
Cell; 2018 Feb; 172(4):719-730.e14. PubMed ID: 29398112
[TBL] [Abstract][Full Text] [Related]
9. Predicted structures and dynamics for agonists and antagonists bound to serotonin 5-HT2B and 5-HT2C receptors.
Kim SK; Li Y; Abrol R; Heo J; Goddard WA
J Chem Inf Model; 2011 Feb; 51(2):420-33. PubMed ID: 21299232
[TBL] [Abstract][Full Text] [Related]
10. Design, Synthesis, and Characterization of 4-Undecylpiperidine-2-carboxamides as Positive Allosteric Modulators of the Serotonin (5-HT) 5-HT
Wild CT; Miszkiel JM; Wold EA; Soto CA; Ding C; Hartley RM; White MA; Anastasio NC; Cunningham KA; Zhou J
J Med Chem; 2019 Jan; 62(1):288-305. PubMed ID: 29620897
[TBL] [Abstract][Full Text] [Related]
11. A novel aminotetralin-type serotonin (5-HT) 2C receptor-specific agonist and 5-HT2A competitive antagonist/5-HT2B inverse agonist with preclinical efficacy for psychoses.
Canal CE; Morgan D; Felsing D; Kondabolu K; Rowland NE; Robertson KL; Sakhuja R; Booth RG
J Pharmacol Exp Ther; 2014 May; 349(2):310-8. PubMed ID: 24563531
[TBL] [Abstract][Full Text] [Related]
12. Design and Discovery of Functionally Selective Serotonin 2C (5-HT
Cheng J; McCorvy JD; Giguere PM; Zhu H; Kenakin T; Roth BL; Kozikowski AP
J Med Chem; 2016 Nov; 59(21):9866-9880. PubMed ID: 27726356
[TBL] [Abstract][Full Text] [Related]
13. We Need 2C but Not 2B: Developing Serotonin 2C (5-HT2C) Receptor Agonists for the Treatment of CNS Disorders.
Cheng J; Kozikowski AP
ChemMedChem; 2015 Dec; 10(12):1963-7. PubMed ID: 26507582
[TBL] [Abstract][Full Text] [Related]
14. Altered 5-HT2C receptor agonist-induced responses and 5-HT2C receptor RNA editing in the amygdala of serotonin transporter knockout mice.
Moya PR; Fox MA; Jensen CL; Laporte JL; French HT; Wendland JR; Murphy DL
BMC Pharmacol; 2011 Apr; 11():3. PubMed ID: 21473759
[TBL] [Abstract][Full Text] [Related]
15. Novel (R)-6,6a,7,8,9,10-hexahydro-5H-pyrazino[1,2-a][1,n]naphthyridines as potent and selective agonists of the 5-HT
Schrader TO; Zhu X; Kasem M; Ren A; Liu C; Wu C; Dang H; Le M; Gatlin J; Chase K; Frazer J; Whelan KT; Grottick AJ; Hutton C; Barden J; Chen C; Ortiz A; Feichtinger K; Semple G
Bioorg Med Chem Lett; 2021 Apr; 38():127872. PubMed ID: 33636307
[TBL] [Abstract][Full Text] [Related]
16. Discovery of a lead series of potent benzodiazepine 5-HT
Ren A; Zhu X; Feichtinger K; Lehman J; Kasem M; Schrader TO; Wong A; Dang H; Le M; Frazer J; Unett DJ; Grottick AJ; Whelan KT; Morgan ME; Sage CR; Semple G
Bioorg Med Chem Lett; 2020 Mar; 30(5):126929. PubMed ID: 31952960
[TBL] [Abstract][Full Text] [Related]
17. Endogenous 5-HT2C Receptors Phosphorylate the cAMP Response Element Binding Protein via Protein Kinase C-Promoted Activation of Extracellular-Regulated Kinases-1/2 in Hypothalamic mHypoA-2/10 Cells.
Lauffer L; Glas E; Gudermann T; Breit A
J Pharmacol Exp Ther; 2016 Jul; 358(1):39-49. PubMed ID: 27189964
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and Biological Evaluation of Disubstituted Pyrimidines as Selective 5-HT
Kim J; Kim YJ; Londhe AM; Pae AN; Choo H; Kim HJ; Min SJ
Molecules; 2019 Sep; 24(18):. PubMed ID: 31491978
[TBL] [Abstract][Full Text] [Related]
19. Identification of Optically Active Pyrimidine Derivatives as Selective 5-HT
Kim J; Jo H; Lee H; Choo H; Kim HJ; Pae AN; Cho YS; Min SJ
Molecules; 2017 Aug; 22(9):. PubMed ID: 28846591
[TBL] [Abstract][Full Text] [Related]
20. Tetrahydroquinoline-based tricyclic amines as potent and selective agonists of the 5-HT
Schrader TO; Kasem M; Ren A; Feichtinger K; Al Doori B; Wei J; Wu C; Dang H; Le M; Gatlin J; Chase K; Dong J; Whelan KT; Sage C; Grottick AJ; Semple G
Bioorg Med Chem Lett; 2016 Dec; 26(24):5877-5882. PubMed ID: 27864071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
